menu
    • menu

    Company profile for CG Oncology

    Rochem, your partner in developing, sourcing, and supplying pharmaceutical & animal health ingredients of Chinese origin.

    Virtual Booth

    Contact Supplier

    DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2025-12-22

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    HTL Biotechnology is a French biotech & a global leader in the responsible development & production of pharma-grade biopolymers.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    CG Oncology, previously known as Cold Genesys, is a clinical-stage immuno-oncology company focused on the development of oncolytic immunotherapies to combat cancer. The company’s lead candidate CG0070 has completed an investigation in a Phase 2, single-arm, open-label, multicenter study (BOND2) for patients with NMIBC who failed BCG therapy and refused cystectomy. In addition, CG Oncology is exploring the use of CG0070 in co...
    CG Oncology, previously known as Cold Genesys, is a clinical-stage immuno-oncology company focused on the development of oncolytic immunotherapies to combat cancer. The company’s lead candidate CG0070 has completed an investigation in a Phase 2, single-arm, open-label, multicenter study (BOND2) for patients with NMIBC who failed BCG therapy and refused cystectomy. In addition, CG Oncology is exploring the use of CG0070 in combination with immune checkpoint inhibitors in different solid tumors. Learn more at www.cgoncology.com.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    CG OncologyUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    400 Spectrum Center Drive ​Suite #2040 ​Irvine, CA 92618
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.cgoncology.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/cold-genesys/about/
    youtube
    YouTube
    Twitter
    Twitter
    https://x.com/coldgenesys

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Tides Asia

    Tides Asia

    Not Confirmed

    envelop Contact Supplier

    Tides Asia

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Cretostimogene Grenadenorepvec Shows Potential As Key Therapy
    Cretostimogene Grenadenorepvec Shows Potential As Key Therapy

    05 Dec 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/12/05/3200708/0/en/New-Cretostimogene-Grenadenorepvec-Data-Highlight-its-Potential-to-Become-the-Backbone-Therapy-for-High-Risk-Non-Muscle-Invasive-Bladder-Cancer.html

    GLOBENEWSWIRE
    05 Dec 2025
    Share Share
    CG Oncology Announces New Board Member And Board Transition
    CG Oncology Announces New Board Member And Board Transition

    26 Nov 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/11/26/3194997/0/en/CG-Oncology-Announces-New-Board-Member-and-Board-Transition.html

    GLOBENEWSWIRE
    26 Nov 2025
    Share Share
    CG Oncology To Unveil Cretostimogene Grenadenorepvec Data At SUO
    CG Oncology To Unveil Cretostimogene Grenadenorepvec Data At SUO

    25 Nov 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/11/25/3194724/0/en/CG-Oncology-to-Present-Results-on-Cretostimogene-Grenadenorepvec-at-the-Society-of-Urologic-Oncology-SUO-26th-Annual-Meeting.html

    GLOBENEWSWIRE
    25 Nov 2025
    Share Share
    CG Oncology Reveals Q3 2025 Financials & Business Updates
    CG Oncology Reveals Q3 2025 Financials & Business Updates

    14 Nov 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/11/14/3188254/0/en/CG-Oncology-Reports-Third-Quarter-2025-Financial-Results-and-Provides-Business-Updates.html

    GLOBENEWSWIRE
    14 Nov 2025
    Share Share
    CG Oncology Shows Durable Tolerability in BOND-003 Cohort C trial
    CG Oncology Shows Durable Tolerability in BOND-003 Cohort C trial

    05 Sep 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/09/05/3145193/0/en/CG-Oncology-Continues-to-Demonstrate-Best-in-Disease-Durability-and-Tolerability-in-BOND-003-Cohort-C-Additional-12-Patients-in-Complete-Response-at-24-Months.html

    GLOBENEWSWIRE
    05 Sep 2025
    Share Share
    CG Oncology Completes Enrollment in PIVOT-006
    CG Oncology Completes Enrollment in PIVOT-006

    03 Sep 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/09/03/3143564/0/en/CG-Oncology-Completes-Enrollment-in-PIVOT-006.html

    GLOBENEWSWIRE
    03 Sep 2025
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search